Related references
Note: Only part of the references are listed.The PMP22 Gene and Its Related Diseases
Jun Li et al.
MOLECULAR NEUROBIOLOGY (2013)
Identification of Drug Modulators Targeting Gene-Dosage Disease CMT1A
Sung-Wook Jang et al.
ACS CHEMICAL BIOLOGY (2012)
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease
Robert Fledrich et al.
BRITISH MEDICAL BULLETIN (2012)
Charcot-Marie-Tooth disease: Emerging mechanisms and therapies
Constantin d'Ydewalle et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Rac1 Controls Schwann Cell Myelination through cAMP and NF2/merlin
Li Guo et al.
JOURNAL OF NEUROSCIENCE (2012)
P2Y11 Purinoceptor Mediates the ATP-Enhanced Chemotactic Response of Rat Neutrophils
Feras Alkayed et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Molecular mechanisms regulating myelination in the peripheral nervous system
Jorge A. Pereira et al.
TRENDS IN NEUROSCIENCES (2012)
Inherited Neuropathies
Angelo Schenone et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
Davide Pareyson et al.
LANCET NEUROLOGY (2011)
A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain
R. D. Ando et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Diadenosine Homodinucleotide Products of ADP-ribosyl Cyclases Behave as Modulators of the Purinergic Receptor P2X7
Santina Bruzzone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Schwann Cell Dedifferentiation Is Independent of Mitogenic Signaling and Uncoupled to Proliferation ROLE OF cAMP AND JNK IN THE MAINTENANCE OF THE DIFFERENTIATED STATE
Paula V. Monje et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathways
Lars-Ove Brandenburg et al.
MOLECULAR IMMUNOLOGY (2010)
Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP
Jin Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies
Giorgia Melli et al.
EXPERT OPINION ON DRUG DISCOVERY (2009)
P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A Neuropathy
Lucilla Nobbio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Discovery and Biological Evaluation of Novel Cyanoguanidine P2X7 Antagonists with Analgesic Activity in a Rat Model of Neuropathic Pain
Arturo Perez-Medrano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A G Protein-Coupled Receptor Is Essential for Schwann Cells to Initiate Myelination
Kelly R. Monk et al.
SCIENCE (2009)
Emerging Roles of NAD+ and Its Metabolites in Cell Signaling
Friedrich Koch-Nolte et al.
SCIENCE SIGNALING (2009)
Negative Regulation of Myelination: Relevance for Development, Injury, and Demyelinating Disease
Kristjan R. Jessen et al.
GLIA (2008)
Adenylic Dinucleotides Produced by CD38 Are Negative Endogenous Modulators of Platelet Aggregation
Mirko Magnone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Simple synthesis of (PP2)-P-1-diadenosine 5 '-pyrophosphate
Enrico Millo et al.
SYNTHETIC COMMUNICATIONS (2008)
Ascorbic acid inhibits PMP22 expression by reducing cAMP levels
Ferdinand Kaya et al.
NEUROMUSCULAR DISORDERS (2007)
Mitochondrial dysfunction induced by a cytotoxic adenine dinucleotide produced by ADP-ribosyl cyclases from cADPR
Santina Bruzzone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
Gerd Meyer zu Horste et al.
ANNALS OF NEUROLOGY (2007)
Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes
Iliana Moreschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease
L Nobbio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
Ivar von Kuegelgen
PHARMACOLOGY & THERAPEUTICS (2006)
Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency
H Ullmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
ADP-ribosyl cyclases generate two unusual adenine homodinucleotides with cytotoxic activity on mammalian cells
G Basile et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR)
AH Guse
FEBS JOURNAL (2005)
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease
E Passage et al.
NATURE MEDICINE (2004)
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease
L Nobbio et al.
NEUROBIOLOGY OF DISEASE (2004)
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
MW Sereda et al.
NATURE MEDICINE (2003)
Immunocyte Ca2+ influx system mediated by LTRPC2
Y Sano et al.
SCIENCE (2001)
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A
L Nobbio et al.
ANNALS OF NEUROLOGY (2001)
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
AL Perraud et al.
NATURE (2001)
Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase
AD Qi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers
HC Lee
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Molecular dissection of the Schwann cell specific promoter of the PMP22 gene
D Sabéran-Djoneidi et al.
GENE (2000)
Share Paper
